Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Oduori OS, Murao N, Shimomura K et al (2020) Gs/Gq signaling switch in cells defines incretin effectiveness in diabetes
Turk J Med Sci 50:17281738
Exercise: A Drug-Free Approach to Lowering High Blood Pressure
This piece is part of a series that dives deeper into this years iteration of our flagship research piece, Charting Disruption
Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost Its Place? Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, vol
/assets/images/provider/photos/2775905.jpeg)
This analysis examines publicly available formularies of plans available on the federally facilitated Affordable Care Act (ACA) Marketplace in 2024 to identify how utilization management tools are used for GLP-1 agonists
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
